Back
Kymera Therapeutics Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Buy
78
KYMR
Kymera Therapeutics
Last Price:
50.04
Seasonality Move:
52.76%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- The current trend is moderately bullish and KYMR is experiencing selling pressure, which indicates risk of future bearish movement.
Kymera Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.7 | Buy |
| 20-day SMA: | 48.07 | Buy |
| 50-day SMA: | 47.17 | Buy |
| 200-day SMA: | 40.35 | Buy |
| 8-day EMA: | 49.53 | Buy |
| 20-day EMA: | 48.27 | Buy |
| 50-day EMA: | 46.83 | Buy |
| 200-day EMA: | 40.04 | Buy |
Kymera Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.01 | Buy |
| Relative Strength Index (14 RSI): | 65.42 | Buy |
| Chaikin Money Flow: | -224866 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.67 - 49.59) | Buy |
| Bollinger Bands (100): | (38.28 - 49.68) | Buy |
Kymera Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics Stock
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 51.83 while KYMR 8-day simple moving average is 48.70, which is a Buy signal.
- The stock price of KYMR is 51.83 while Kymera Therapeutics 20-day SMA is 48.07, which makes it a Buy.
- Kymera Therapeutics 50-day simple moving average is 47.17 while KYMR share price is 51.83, making it a Buy technically.
- KYMR stock price is 51.83 and Kymera Therapeutics 200-day simple moving average is 40.35, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
78
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy or a Sell?
-
Kymera Therapeutics stock is rated a Buy
The current Kymera Therapeutics [KYMR] share price is $51.83. The Score for KYMR is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics Stock Info
Market Cap:
3.36B
Price in USD:
51.83
Share Volume:
392.41K
Kymera Therapeutics 52-Week Range
52-Week High:
53.27
52-Week Low:
13.96
Buy
78
Kymera Therapeutics (KYMR)
is a Buy
Kymera Therapeutics Share Price Forecast
-
What is the Kymera Therapeutics stock price today?
The Kymera Therapeutics stock price is 51.83 USD today. -
Will KYMR stock go up or go down?
Kymera Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Kymera Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics is not overvalued.
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 51.83 while KYMR 8-day exponential moving average is 49.53, which is a Buy signal.
- The stock price of KYMR is 51.83 while Kymera Therapeutics 20-day EMA is 48.27, which makes it a Buy.
- Kymera Therapeutics 50-day exponential moving average is 46.83 while KYMR share price is 51.83, making it a Buy technically.
- KYMR stock price is 51.83 and Kymera Therapeutics 200-day simple moving average is 40.04, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics
Is Kymera Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.50 per share.
Technical Analysis of Kymera Therapeutics
Should I short Kymera Therapeutics stock?
- KYMR Moving Average Covergence Divergence (MACD) indicator is 1.01, suggesting Kymera Therapeutics is a Buy
- Kymera Therapeutics Relative Strength Index (RSI) is 65.42, which suggest Kymera Therapeutics is overbought
- The Bollinger Bands (25) for Kymera Therapeutics is (44.67 - 49.59), which suggest Kymera Therapeutics is a Buy
- The Bollinger Bands (100) for Kymera Therapeutics is (38.28 - 49.68), which suggest Kymera Therapeutics is a Buy
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.